Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.56
-0.18 (-0.67%)
At close: Dec 26, 2024, 4:00 PM
26.54
-0.02 (-0.08%)
After-hours: Dec 26, 2024, 7:58 PM EST
Pfizer Employees
Pfizer had 88,000 employees as of December 31, 2023. The number of employees increased by 5,000 or 6.02% compared to the previous year.
Employees
88,000
Change (1Y)
5,000
Growth (1Y)
6.02%
Revenue / Employee
$674,716
Profits / Employee
$48,318
Market Cap
150.52B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 88,000 | 5,000 | 6.02% |
Dec 31, 2022 | 83,000 | 4,000 | 5.06% |
Dec 31, 2021 | 79,000 | 500 | 0.64% |
Dec 31, 2020 | 78,500 | -9,800 | -11.10% |
Dec 31, 2019 | 88,300 | -4,100 | -4.44% |
Dec 31, 2018 | 92,400 | 2,200 | 2.44% |
Dec 31, 2017 | 90,200 | -6,300 | -6.53% |
Dec 31, 2016 | 96,500 | -1,400 | -1.43% |
Dec 31, 2015 | 97,900 | 19,600 | 25.03% |
Dec 31, 2014 | 78,300 | 600 | 0.77% |
Dec 31, 2013 | 77,700 | -13,800 | -15.08% |
Dec 31, 2012 | 91,500 | -12,200 | -11.76% |
Dec 31, 2011 | 103,700 | -6,900 | -6.24% |
Dec 31, 2010 | 110,600 | -5,900 | -5.06% |
Dec 31, 2009 | 116,500 | 34,700 | 42.42% |
Dec 31, 2008 | 81,800 | -4,800 | -5.54% |
Dec 31, 2007 | 86,600 | -11,400 | -11.63% |
Dec 31, 2006 | 98,000 | -8,000 | -7.55% |
Dec 31, 2005 | 106,000 | -9,000 | -7.83% |
Dec 31, 2004 | 115,000 | -7,000 | -5.74% |
Dec 31, 2003 | 122,000 | 24,000 | 24.49% |
Dec 31, 2002 | 98,000 | 8,000 | 8.89% |
Dec 31, 2001 | 90,000 | 0 | - |
Dec 31, 2000 | 90,000 | 39,100 | 76.82% |
Dec 31, 1999 | 50,900 | 4,500 | 9.70% |
Dec 31, 1998 | 46,400 | -2,800 | -5.69% |
Dec 31, 1997 | 49,200 | 2,700 | 5.81% |
Dec 31, 1996 | 46,500 | 2,700 | 6.16% |
Dec 31, 1995 | 43,800 | 3,000 | 7.35% |
Dec 31, 1994 | 40,800 | 300 | 0.74% |
Dec 31, 1993 | 40,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
Sanofi | 86,088 |
Novartis AG | 76,057 |
Danaher | 63,000 |
Boston Scientific | 48,000 |
Bristol-Myers Squibb Company | 34,100 |
Amgen | 26,700 |
PFE News
- 11 hours ago - Dividend Harvesting Portfolio Week 199: $19,900 Allocated, $1,908.79 In Projected Dividends - Seeking Alpha
- 2 days ago - If You Could Only Buy One: 5 Top Dividend Stocks For The Next 10 Years - Seeking Alpha
- 3 days ago - Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction - Benzinga
- 3 days ago - Pfizer's 2025 'Boring' Outlook Had A Nice Surprise That Was Overlooked - Seeking Alpha
- 6 days ago - U.S. FDA Approves Pfizer's BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer - Business Wire
- 7 days ago - Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts - Business Wire
- 7 days ago - Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature - Business Wire
- 8 days ago - Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) - Seeking Alpha